Matt Tschantz

Matt Tschantz is a seasoned scientist with extensive experience in the pharmaceutical industry, currently serving as Principal Investigator at Vividion Therapeutics, Inc. since November 2023. Prior to this role, Matt held the position of Senior Scientist at ImmuneSensor Therapeutics from July 2017 to November 2023 and worked at Boehringer Ingelheim Pharmaceuticals from December 1994 to February 2017, where contributions were made as both Senior Scientist and in various Scientist roles. Matt Tschantz holds a Master of Science degree in Organic Chemistry from Colorado State University and a Bachelor of Science degree in Chemistry with Honors from Southern Methodist University. Education was initiated at Lake Highlands High School, culminating in 1987.